New proposals on food dyes, ivermectin, and medical training raise questions about science, policy, and priorities

A package of public health legislation moving through the Iowa Legislature aligned with the “Make America Healthy Again” (MAHA) movement has sparked debate over what constitutes sound health policy and what may instead reflect political influence.

The proposals, backed by Governor Kim Reynolds and Republican majorities, include measures related to restrictions on artificial food dyes in school meals, changes to SNAP food eligibility, nutrition and physical activity initiatives, required nutrition education for physicians, and notably, allowing pharmacists to dispense ivermectin.

Where Policy Meets Controversy

At a high level, many elements of the legislation are difficult to dispute. Improving childhood nutrition, addressing obesity, encouraging physical activity, and promoting healthier food choices are all non-controversial and legitimate public health goals.

But the concern is not with the goals. It is with how they are being pursued, and what is being included alongside them.

Ivermectin: A Policy Flashpoint

One of the most controversial provisions allows pharmacists to dispense ivermectin. Ivermectin is a legitimate antiparasitic medication that is widely used in both human and veterinary medicine.

However, it has been extensively studied and discredited as a treatment for COVID-19 by the U.S. Food and Drug Administration and the broader medical community. Including it in public health legislation raises concerns that policy is being influenced by previous misinformation narratives, and scientific consensus is being undermined or selectively ignored.

Artificial Dyes: A More Nuanced Issue

The proposed restrictions on artificial dyes present a different kind of challenge. Unlike ivermectin, there is ongoing scientific debate about certain food additives and some countries have stricter regulations than the United States. However, federal regulators have not implemented broad bans, and recent signals suggest a more cautious, evidence-based approach rather than sweeping restrictions.

This raises an important policy question. Should individual states move ahead of federal science, or align with it?

Who Decides Medical Training?

Another provision would require expanded nutrition education for physicians and medical students. On its face, this may seem reasonable. But critics point out that medical education is typically governed by accredited institutions and professional bodies. Mandating curriculum changes through state legislation risks politicizing medical training and overriding established expertise.

The SNAP Debate: Nutrition vs. Access

Changes to SNAP eligibility also highlight competing priorities. Supporters argue that public funds should promote healthier food choices. Critics counter that current eligibility rules are based on tax classification, not nutrition science. Restrictions could reduce access for families already under financial strain.

The result is a tension between public health goals and economic reality for working families.

A Broader Pattern

Taken together, the legislation reflects a broader pattern where legitimate health concerns are paired with more controversial provisions, scientific consensus is inconsistently applied, and policy decisions intersect with political messaging.

This creates a fundamental question. Is this a coordinated public health strategy or a collection of ideas driven by multiple, sometimes conflicting influences?

Iowa411 Perspective

Improving public health is a worthy goal. But effective policy requires consistency, scientific alignment, and clear prioritization.

When legislation combines evidence-based measures with provisions tied to disputed or discredited claims, it risks undermining its own credibility.

The Bottom Line

Iowa’s MAHA legislation raises important questions. Not just about health policy, but about how that policy is formed. Are decisions grounded in current scientific consensus? Are priorities aligned with real-world needs? And are public health goals being advanced, or made more complicated?

These are questions worth asking as the legislation moves forward.